Sano Genetics/X
Jul 31, 2025, 15:37
Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab
Sano Genetics shared an inviting post on X:
”Tune in to Episode 198 of The Genetics Podcast.
This week, we’re joined by Benny Sorensen, CEO of Hemab Therapeutics. Tune in to hear about how Benny’s persistence and “unreasonable” leadership led to Hemab’s first program, how Hemab is reimagining clotting therapies by centering patient voices, and the value of their multi-modality and collaborative approach.”
Listen to the Apple Podcast here.
Listen to the YouTube Podcast here.
Stay tuned with Hemostasis Today.
-
Feb 8, 2026, 16:12Ney Carter Borges: How RSV Hospitalization is Linked to Sharp Rise in Heart Attack and Stroke Risk
-
Feb 8, 2026, 16:07New BSH–UKHCDO Guideline on Acquired Coagulation Factor Inhibitors
-
Feb 8, 2026, 16:04Mahesan Subramaniam: Pomegranate Juice and Heart Health
-
Feb 8, 2026, 16:02Mark Young: The More Science Listens, the More It Hears – Matter, Frequency, and Resonance
-
Feb 8, 2026, 15:53Julieta Rosales: ISC 2026 Data on Intravenous Thrombolysis in the Late Window
-
Feb 8, 2026, 15:51Alison L. Bailey: Wearing Red to Raise Awareness of Women’s N1 Killer on National Go Red Day
-
Feb 8, 2026, 15:44Jan Sloves։ Pedal Venous Maturation Predicts Limb Salvage in No‑Option CLTI
-
Feb 8, 2026, 15:26Abdulrahman Katib։ Anticoagulate or Observe? A Practical Approach to Isolated Distal DVT
-
Feb 8, 2026, 15:24Irma Bagdoniene։ Why Intensive Prevention is the Most Rational Strategy in Preventive Cardiology